Newtekone . 8.50% Fixed Rate Senior Notes Due 2029 Earnings Calls
| Release date | Apr 30, 2026 |
| EPS estimate | $0.420 |
| EPS actual | $0.393 |
| EPS Surprise | -6.29% |
| Revenue estimate | 75.767M |
| Revenue actual | 70.957M |
| Revenue Surprise | -6.35% |
| Release date | Jan 29, 2026 |
| EPS estimate | $0.682 |
| EPS actual | $0.613 |
| EPS Surprise | -10.12% |
| Revenue estimate | 80.008M |
| Revenue actual | 73.333M |
| Revenue Surprise | -8.34% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.640 |
| EPS actual | - |
| Revenue estimate | 78.306M |
| Revenue actual | 85.49M |
| Revenue Surprise | 9.17% |
| Release date | Jul 28, 2025 |
| EPS estimate | $0.520 |
| EPS actual | - |
| Revenue estimate | 73.885M |
| Revenue actual | 77.267M |
| Revenue Surprise | 4.58% |
Last 4 Quarters for Newtekone . 8.50% Fixed Rate Senior Notes Due 2029
Below you can see how NEWTG performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 28, 2025 |
| Price on release | $25.07 |
| EPS estimate | $0.520 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 22, 2025 | $25.25 |
| Jul 23, 2025 | $25.18 |
| Jul 24, 2025 | $25.15 |
| Jul 25, 2025 | $25.09 |
| Jul 28, 2025 | $25.07 |
| Jul 29, 2025 | $25.25 |
| Jul 30, 2025 | $25.25 |
| Jul 31, 2025 | $25.23 |
| Aug 01, 2025 | $25.15 |
| 4 days before | -0.713% |
| 4 days after | 0.319% |
| On release day | 0.718% |
| Change in period | -0.396% |
| Release date | Oct 29, 2025 |
| Price on release | $25.13 |
| EPS estimate | $0.640 |
| EPS actual | - |
| Date | Price |
|---|---|
| Oct 23, 2025 | $25.15 |
| Oct 24, 2025 | $25.21 |
| Oct 27, 2025 | $25.25 |
| Oct 28, 2025 | $25.23 |
| Oct 29, 2025 | $25.13 |
| Oct 30, 2025 | $25.20 |
| Oct 31, 2025 | $25.30 |
| Nov 03, 2025 | $25.32 |
| Nov 04, 2025 | $25.24 |
| 4 days before | -0.0795% |
| 4 days after | 0.438% |
| On release day | 0.279% |
| Change in period | 0.358% |
| Release date | Jan 29, 2026 |
| Price on release | $25.29 |
| EPS estimate | $0.682 |
| EPS actual | $0.613 |
| EPS surprise | -10.12% |
| Date | Price |
|---|---|
| Jan 23, 2026 | $25.28 |
| Jan 26, 2026 | $25.41 |
| Jan 27, 2026 | $25.34 |
| Jan 28, 2026 | $25.30 |
| Jan 29, 2026 | $25.29 |
| Jan 30, 2026 | $25.32 |
| Feb 02, 2026 | $25.40 |
| Feb 03, 2026 | $25.31 |
| Feb 04, 2026 | $25.36 |
| 4 days before | 0.0400% |
| 4 days after | 0.257% |
| On release day | 0.118% |
| Change in period | 0.297% |
| Release date | Apr 30, 2026 |
| Price on release | $25.50 |
| EPS estimate | $0.420 |
| EPS actual | $0.393 |
| EPS surprise | -6.29% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $25.38 |
| Apr 27, 2026 | $25.35 |
| Apr 28, 2026 | $25.32 |
| Apr 29, 2026 | $25.47 |
| Apr 30, 2026 | $25.50 |
| May 01, 2026 | $25.55 |
| May 04, 2026 | $25.57 |
| May 05, 2026 | $25.65 |
| May 06, 2026 | $25.65 |
| 4 days before | 0.472% |
| 4 days after | 0.589% |
| On release day | 0.196% |
| Change in period | 1.06% |
Newtekone . 8.50% Fixed Rate Senior Notes Due 2029 Earnings Call Transcript Summary of Q1 2026
NewtekOne reported a strong start to 2026 with Q1 EPS of $0.43 (above consensus), double-digit year-over-year EPS growth, and continued tangible book value expansion (tangible BV/share $11.84). Management reaffirmed 2026 guidance (midpoint $2.35) and provided a 2027 midpoint estimate of $2.60. Loan originations accelerated (961 units, +40% YoY; $391M vs $366M prior year) with March/April momentum and continued deposit growth (37,000 accounts; deposits grown from $142M at acquisition to ~$1.9B). Key strategic shifts: moving larger C&I long-amortizing (C&I LA) originations into the bank to fund with lower-cost core deposits (improving margins vs prior warehouse funding/securitization), continued use of securitizations for scale, and digital/AI-enabled underwriting (including a 7-day small business loan capability). Credit metrics at the bank have stabilized: delinquencies and nonperforming loans (excluding government-guaranteed loans) declined sequentially, CECL-driven allowances were built proactively as the loan book seasoned, and provisioning has covered net charge-offs. Capital ratios remain healthy (leverage >13%, CET1 >15.5%, Tier 1 >18%, total ~19.5%). Management plans controlled, diversified growth (low-double-digit loan growth target) and expects NII and margins to benefit as higher-yielding loans and lower-cost deposit funding continue to scale. They highlighted adoption of real-time payments (FedNow and RTP live) as a competitive deposit/transaction advantage.
Sign In
Buy NEWTG